I think good news on the following, finance, patients and new patients in 3 separate RNSs will put this up to about £15 with ease. Hopefully starting this week.
I have been on LSE since 2005 but with a big gap till August this year when I learnt of HEMO through a good friend of mine who has a major reported holding in this company. I now have a good holding and believe in the science. I just hope that the commercial side of HEMO can take this forward and get the product worldwide. This is a life changer for patients and the LTH who have supported this venture.